{
    "root": "21b1c7cb-edb9-4e64-b04d-e9d27d6efb2b",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Ciprofloxacin",
    "value": "20250228",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MODIFIED CORN STARCH (1-OCTENYL SUCCINIC ANHYDRIDE)",
            "code": "461P5CJN6T",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A CORN",
            "code": "AG9B65PV6B",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "HYPROMELLOSE, UNSPECIFIED",
            "code": "3NXW29V3WO",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        },
        {
            "name": "POLYETHYLENE GLYCOL, UNSPECIFIED",
            "code": "3WJQ0SDW1A",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "CIPROFLOXACIN HYDROCHLORIDE",
            "code": "4BA73M5E37",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        }
    ],
    "indications": {
        "text": "ciprofloxacin fluoroquinolone antibacterial indicated adults ( 18 years age older ) following infections caused designated , susceptible bacteria pediatric patients indicated : \u2022 skin skin structure infections ( error ! hyperlink reference valid . ) \u2022 bone joint infections ( 1.2 ) \u2022 complicated intra-abdominal infections ( 1.3 ) \u2022 infectious diarrhea ( 1.4 ) \u2022 typhoid fever ( enteric fever ) ( 1.5 ) \u2022 uncomplicated cervical urethral gonorrhea ( 1.6 ) \u2022 inhalational anthrax post-exposure adult pediatric patients ( 1.7 ) \u2022 plague adult pediatric patients ( 1.8 ) \u2022 chronic bacterial prostatitis ( 1.9 ) \u2022 lower respiratory tract infections ( 1.10 ) \u2022 acute exacerbation chronic bronchitis \u2022 urinary tract infections ( 1.11 ) \u2022 urinary tract infections ( uti ) \u2022 acute uncomplicated cystitis \u2022 complicated uti pyelonephritis pediatric patients \u2022 acute sinusitis ( 1.12 ) usage reduce development drug-resistant bacteria maintain effectiveness ciprofloxacin antibacterial drugs , ciprofloxacin used treat prevent infections proven strongly suspected caused bacteria . ( 1.13 )",
        "doid_entities": [
            {
                "text": "infectious diarrhea (DOID:12384)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_12384"
            },
            {
                "text": "diarrhea (DOID:13250)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13250"
            },
            {
                "text": "typhoid (DOID:13258)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_13258"
            },
            {
                "text": "gonorrhea (DOID:7551)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_7551"
            },
            {
                "text": "plague (DOID:3482)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_3482"
            },
            {
                "text": "prostatitis (DOID:14654)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_14654"
            },
            {
                "text": "chronic bronchitis (DOID:6132)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_6132"
            },
            {
                "text": "uti (DOID:0080784)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0080784"
            },
            {
                "text": "cystitis (DOID:1679)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_1679"
            },
            {
                "text": "pyelonephritis (DOID:11400)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_11400"
            },
            {
                "text": "sinusitis (DOID:0050127)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0050127"
            }
        ],
        "orphanet_entities": [
            {
                "disease": "acute uncomplicated cystitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_156149"
            },
            {
                "disease": "chronic bacterial prostatitis",
                "orphanet_id": "http://www.orpha.net/ORDO/Orphanet_330064"
            }
        ]
    },
    "contraindications": {
        "text": "ciprofloxacin tablets administered orally described appropriate guidelines tables .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "ciprofloxacin tablets , usp 250 mg available round , white film-coated tablets debossed \u201c y101 \u201d one side . bottles 10 tablets ndc 68788-8200-1 bottles 20 tablets ndc 68788-8200-2 bottles 30 tablets ndc 68788-8200-3 store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . preserve well-closed container .",
    "adverseReactions": "\u2022 known hypersensitivity ciprofloxacin quinolones ( error ! hyperlink reference valid . , 5.6 , 5.7 ) \u2022 concomitant tizanidine ( 4.2 )",
    "indications_original": "Ciprofloxacin is a fluoroquinolone antibacterial indicated in adults (18 years of age and older) with the following infections caused by designated, susceptible bacteria and in pediatric patients where indicated: \u2022 Skin and Skin Structure Infections ( Error! Hyperlink reference not valid. ) \u2022 Bone and Joint Infections ( 1.2 ) \u2022 Complicated Intra-Abdominal Infections ( 1.3 ) \u2022 Infectious Diarrhea ( 1.4 ) \u2022 Typhoid Fever (Enteric Fever) ( 1.5 ) \u2022 Uncomplicated Cervical and Urethral Gonorrhea ( 1.6 ) \u2022 Inhalational Anthrax post-exposure in adult and pediatric patients ( 1.7) \u2022 Plague in adult and pediatric patients ( 1.8 ) \u2022 Chronic Bacterial Prostatitis ( 1.9 ) \u2022 Lower Respiratory Tract Infections ( 1.10 ) \u2022 Acute Exacerbation of Chronic Bronchitis \u2022 Urinary Tract Infections ( 1.11 ) \u2022 Urinary Tract Infections (UTI) \u2022 Acute Uncomplicated Cystitis \u2022 Complicated UTI and Pyelonephritis in Pediatric Patients \u2022 Acute Sinusitis ( 1.12 ) Usage To reduce the development of drug-resistant bacteria and maintain the effectiveness of ciprofloxacin and other antibacterial drugs, ciprofloxacin should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.\u00a0( 1.13 )",
    "contraindications_original": "Ciprofloxacin tablets should be administered orally as described in the appropriate Dosage Guidelines tables.",
    "warningsAndPrecautions_original": "Ciprofloxacin Tablets, USP 250 mg are available as round, white film-coated tablets debossed with \u201cY101\u201d on one side.  \n                  \n                     \n                        \u00a0In bottles of 10 Tablets\tNDC 68788-8200-1\n                     \n                        \u00a0In bottles of 20 Tablets\tNDC 68788-8200-2\n                     \n                        \u00a0In bottles of 30 Tablets\tNDC 68788-8200-3\n                  \n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature]. Preserve in well-closed container.",
    "adverseReactions_original": "\u2022\u00a0 Known hypersensitivity to\u00a0ciprofloxacin or other quinolones ( Error! Hyperlink reference not valid. , 5.6 , 5.7) \u2022\u00a0 Concomitant administration with tizanidine ( 4.2 )",
    "drug": [
        {
            "name": "Ciprofloxacin",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_100241"
        }
    ]
}